Ylitornio, Finland

Juha Yrjänheikki

This inventor holds 1 USPTO granted patent. Top assignee: Bioabsorbable Concepts, Inc.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Juha Yrjänheikki. Retrieved from https://idiyas.com/inventor/juha-yrjandaumlnheikki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Juha Yrjänheikki: Innovator in Cerebrovascular Treatment

Introduction

Juha Yrjänheikki is a notable inventor based in Ylitornio, Finland. He has made significant contributions to the field of medicine, particularly in the treatment of cerebrovascular diseases. His innovative approach combines the use of tetracycline and its derivatives to address critical health issues.

Latest Patents

Juha holds a patent for a method that involves the systemic and/or local application of tetracycline and/or tetracycline derivatives. This method is designed for treating, suppressing, and preventing cerebrovascular diseases, traumas, and damages to the nervous system. The patent outlines the use of an effective amount of tetracycline or its derivatives, optionally combined with a pharmaceutically acceptable diluent, carrier, or release system.

Career Highlights

Juha is associated with Bioabsorbable Concepts, Inc., where he continues to develop innovative solutions in the medical field. His work focuses on enhancing treatment methodologies for serious health conditions, showcasing his commitment to improving patient outcomes.

Collaborations

Juha has collaborated with notable colleagues, including Pertti Törmälä and Riitta Keinänen. Their combined expertise contributes to the advancement of medical technologies and treatment options.

Conclusion

Juha Yrjänheikki's contributions to the field of cerebrovascular treatment through his innovative patent demonstrate his dedication to medical advancements. His work continues to impact the healthcare industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…